Soler, Mary Rose .
HRN: 18-53-40 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/23/2024
MUPIROCIN 2%, 15G (TUBE)
09/23/2024
09/30/2024
TOPICAL
Apply On Affected Area
Once A Day
Prophylaxis
Waiting Final Action
Indication: Prophylaxis Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes